On January 7, 2025, the U.S. Food and Drug Administration (“FDA”) issued draft guidance, titled “Artificial ...

FDA published a final version of its guidance document, “Communications From Firms to Health Care Providers Regarding ...

Changes to the FDA labeling guidance in support of FALCPA include alterations to the definitions of “major” food allergens ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

The NGO Doctors for America argued that HHS, CDC and FDA violated federal law in removing medical information from ...

President Trump signed Executive Order 14192 which is formally titled, “Unleashing Prosperity Through Deregulation,” but ...

A federal judge today, February 11, gave the Trump administration until 11:59 pm tonight to restore public documents and datasets that were abruptly removed or altered from federal health websites to ...

While sleep supplements can be beneficial, the lack of regulation means consumers are not assured of a safe and effective ...

Sales of an Alzheimer’s disease treatment were better than expected, but that and a quarterly beat wasn’t enough to offset ...

Eli Lilly reported fourth quarter and full year earnings for 2024 Thursday, with results largely beating Wall Street ...

Incyte has a strong track record of revenue growth and a robust pipeline, targeting over 10 high-impact product launches by ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...